Comparison of baseline parameters between patients who did and did not reach the endpoint defined by an eGFR decline more than 25% from baseline.

Comparison between two groups of patients by the student’s t test, Pearson x2 test, or Mann-Whitney U test, as appropriate.ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; CAD, coronary artery disease; CRP, C-reactive protein; DHP, dihydropyridine; eGFR, estimated glomerular filtration rate; HDL, high density lipoprotein; LDL, low density lipoprotein.